INTRODUCTION
Various sugar analogs containing nitrogen, 1 sulfur, 2 or phosphorus 3 as a ring heteroatom have been prepared because of the wide interest in their chemical and biochemical properties.
Heteroatom-in-the-ring sugar analogs of 2-amino-and 2-acetamido-2-deoxyhexopyranoses, which widely occur as a component of many natural products, have also attracted considerable interest. Azasugar (1) 4 and thiasugar analogs (2) 5 of N-acetyl-D-glucosamine, for example, have been prepared and N-acetylglucosaminidase inhibitory activity of the former has been reported.
In view of such a chemical modification by heteroatoms, we have prepared various sugar analogs having a phosphorus atom in the ring (phospha-sugar); e.g., D-glucopyranose (3) 6 and D-mannopyranose analogs (4) .
7
These phospha-sugar analogs are expected to be of interest in view of potential biological activities, such as glycosidase inhibitory activities 8 and antitumor activities against leukemia cells.
9
Meanwhile, as synthetic N-acetyl-D-glucosamine analogs having phosphorus attached to a sugar-carbon atom, the isosteric phosphonate analog of 1-phosphate (5) 10 and the cyclic phosphonate analog (6) 11 have been prepared. We describe herein the first synthetic route to the N-acetyl-D-glucosamine phospha-sugar (25), by using our effective procedure 12 to introduce a phosphoryl group onto a sugar skeleton; namely addition of a phosphonate to an appropriate hexos-5-ulose derivative and the subsequent deoxygenation.
RESULTS AND DISCUSSION
For the preparation of the key 5-deoxy-5-dimethylphosphoryl-D-glucose precursors (13a and 21a), two synthetic routes by starting with open-chain and furanose derivatives (7 and 15) of N-acetyl-D-glucosamine were employed (Scheme 1 and 3).
First, 2-acetamido-2-deoxy-3,4-O-isopropylidene-D-glucose dimethyl acetal (7) (available from N-acetyl-D-glucosamine in 2 steps) 13 served as the starting material for preparation of the 5-ulose intermediate (10) to introduce a phosphoryl group, as illustrated in Scheme 1. The epoxidation of 7 under Mitsunobu's conditions afforded the 5,6-anhydro derivative (8) (91%), which was then treated with benzyl alcohol and sodium hydride in 1,2-dimethoxyethane (DME) to give the 6-O-benzyl compound (9a) in 87% yield.
As an alternative way for preparation of 9a, the 5,6-diol 7 was treated with dibutyltin oxide in refluxed toluene to give 5,6-O-stannylene acetal, which was subjected to the benzylation with benzyl bromide in the presence of tetrabutylammonium iodide in the same solvent, 14 providing the 6-O-benzyl derivative (9a) (90% yield) together with a trace amount of the 5-O-benzyl isomer (9b) (2%). Swern oxidation of 9a with oxalyl chloride-DMSO afforded the D-xylo-hexos-5-ulose dimethyl acetal (10) in 95%.
The addition reaction of dimethyl phosphonate to 10 in the presence of DBU gave the (5R)-and (5S)-5-C-dimethoxyphosphoryl-D-xylo-hexose derivatives (11) (26% and 54%, respectively).
15
The diastereomeric mixture of 11 was converted to the methoxalyl esters (12) with methoxalyl chloride in the presence of 4-dimethylaminopyridine (DMAP) in 84% yield and then reduced with tributyltin hydride in the presence of AIBN, affording a 72:28 mixture of 5-deoxy products. On structural assignment of the resulting two separable diastereoisomers by 1 H-NMR, it turned out that the major isomer was not the expected 5-deoxy-5-dimethoxyphosphoryl-D-glucose derivative (13a) (23%) but the L-idose isomer (13b) (60%).
Scheme 1
The large J 3,4 values (8.5 and 8.2 Hz) of 13a,b indicate an anti relationship of H-3/H-4 for both isomers.
The D-gluco configuration for 13a was assigned on the basis of the small J 4,P (9.9 Hz) and J 4, 5 (4.1 Hz) values and the presence of a long range coupling, 4 J 3,P (1.5 Hz) 12, 16 (Figure 1) . Similarly, the L-ido configuration for 13b was derived from the relatively large J 4,P (18.2 Hz) and small J 4, 5 (5.3 Hz) values. Alternatively, methyl 2-acetamido-3-O-benzyl-2-deoxy-D-glucofuranose (15) was prepared from N-acetyl-D-glucosamine in 4 steps via 14 with a slight modification of reported procedures 4, 17 (Scheme 2).
The epoxidation of 15 under Mitsunobu's conditions afforded the 5,6-anhydro derivative (16) (87%), which was then treated with benzyl alcohol and sodium hydride to give the 6-O-benzyl compound (17a) in 82% yield. Meanwhile, benzylation of 15 by way of the 5,6-O-stannylene acetal resulted in production of the 6-O-benzyl derivative (17a) (72% yield) and its 5-O-benzyl isomer (17b) (18%) with less selectivity than that from 7. Oxidation of 17a with oxalyl chloride-DMSO afforded the D-xylo-hexofuranosid-5-ulose (18) in 94% yield, while the same reaction with PCC gave 18 in 85%.
Scheme 2
The addition reaction of dimethyl phosphonate to 18 in the presence of DBU provided the (5R)-and (5S)-5-dimethoxyphosphoryl-D-xylo-hexofuranoside derivatives (19) (69% and 25%, respectively).
15
The diastereomeric mixture of 19 was converted to the methoxalyl esters (20) in 85% yield, which were then reduced with tributyltin hydride, affording the 5-deoxy-5-dimethoxyphosphoryl-D-glucofuranoside derivative (21a) (43%) and its L-idofuranoside isomer (21b) (18%) together with dephosphorylated product 18 (12%). The D-gluco configuration for 21a was assigned on the basis of the large J 4,5 value , and its β-anomer (25d) (2.3%) were obtained.
Scheme 3
The similar treatment of the L-idose dimethyl acetal derivative (13b) afforded 2-amino-3,6-di-O-benzyl- 
2-Acetamido-5,6-anhydro-2-deoxy-3,4-O-isopropylidene-D-glucose dimethyl acetal (8).
To a solution of 7 13 (300 mg, 0.976 mmol) and triphenylphosphine (310 mg, 1.18 mmol) in dry toluene (10 mL) was added DEAD (40% in toluene, 0.470 mL, 1.18 mmol). 
2-Acetamido-6-O-benzyl-2-deoxy-3,4-O-isopropylidene-D-glucose dimethyl acetal (9a) and its

5-O-benzyl analog (9b).
A. From 8. To a suspension of sodium hydride (60% in mineral oil, 560 mg, 14.0 mmol) and benzyl alcohol (2.20 mL, 21.3 mmol) in DME (5.0 mL) was added a solution of 8 (2.02 g, 6.98 mmol) in DME (5.0 mL) at 0 °C. The mixture was stirred at 50 °C for 3 h, diluted with saturated NH 4 Cl (20 mL), and extracted with CHCl 3 three times. The combined organic layers were washed with water, dried (Na 2 SO 4 ), and concentrated in vacuo. The residue was purified by column chromatography with 3:1 AcOEt-hexane as an eluant to give 9a (2.44 g, 88%) as colorless needles. 
2-Acetamido-6-O-benzyl-2-deoxy-3,4-O-isopropylidene-D-xylo-hexos-5-ulose dimethyl acetal (10).
To a solution of oxalyl chloride (1.70 mL, 19.5 
(5R)-and (5S)-2-Acetamido-6-O-benzyl-2-deoxy-5-C-dimethoxyphosphoryl-5-O-methoxalyl-3,4-Oisopropylidene-D-xylo-hexose dimethyl acetals (12).
Methoxalyl chloride (0.330 mL, 3.59 mmol) was added to a solution of 11 (40:60 diastereomeric mixture, 
2-Acetamido-6-O-benzyl-2,5-dideoxy-5-dimethoxyphosphoryl-3,4-O-isopropylidene-D-glucose dimethyl acetal (13a) and its L-idose analog (13b).
To a solution of 12 (900 mg, 1.51 mmol) in toluene (6 mL), a solution of AIBN (130 mg 
Methyl 2-acetamido-3-O-benzyl-2-deoxy-β-D-glucofuranoside (15).
5
The following modification of the literature procedures 4 was made. The oxazoline 14 17 (3.93 g, 11.8 mmol) was dissolved in dry MeOH (40 mL) containing 4M HCl (in dioxane, 0.032 mL). The mixture was stirred at rt for 5 h and neutralized with Amberlite-IRA96SB at 0 o C. The resin was filtered off and the filtrate was evaporated in vacuo to give a crude syrup (4.25 g) of methyl 2-acetamido-3-O-benzyl-2-
The above syrup was dissolved in 70% aqueous acetic acid (50 ml) and the mixture was stirred at 40 o C for 6 h. Then the mixture was concentrated in vacuo and the residue was purified by column chromatography with 1:9 MeOH-CHCl 3 to give 15 ( 
Methyl 2-acetamido-5,6-anhydro-3-O-benzyl-2-deoxy-β-D-glucofuranoside (16).
By use of the same procedures described for 8 from 7, compound 15 (2.90 g, 8.91 mmol) was treated with triphenylphosphine (2.83 g, 10.8 mmol) and DEAD (40% in toluene, 4.30 mL, 10.8 mmol) in toluene (60 mL) to give 16 (2.38 g, 87%) as colorless needles: mp 209-210 o C (from AcOEt-hexane); R f = 0.36 (A);
1 H NMR δ = 1.97 (3H, s, NAc), 2.73 (1H, dd, J 6,6' = 5.0, J 5,6' = 2.6 Hz, H'-6), 2.90 (1H, dd, J 5,6 = 4.1 Hz, H-6), 3.41 (ddt, 1H, J 4, 5 = 6.7 Hz, 3.41 (3H, s, 3.84 (1H, t, J 3, 4 = 6.5, A. From 16. By use of the same procedures described for 9a from 8, compound 16 (1.70 g, 5.53 mmol) was treated with benzyl alcohol (2.0 mL, 19.4 mmol) and sodium hydride (60% in mineral oil, 580 mg, 14.5 mmol) in DME (10 mL) to give 17a (1.88 g, 82%) . 
2-Acetamido-1,3,4,6-tetra-O-acetyl-2,5-dideoxy-5-methoxyphosphoryl-D-glucopyranoses (25a-d).
To a This was dissolved in dry pyridine (1.5 mL), and acetic anhydride (0.6 mL, 6.3 mmol) was added at 0 °C.
The mixture was stirred at rt for 15 h, diluted with a small amount of cold water, and concentrated in vacuo. The residue was dissolved in methanol and passed through a column of Amberlite IR-120(H + ) (10 mL). The eluent was evaporated in vacuo and the residue was methylated with (trimethylsilyl)diazomethane (2M in ether, 0.40 mL, 0.80 mmol) in dry CH 2 Cl 2 (1.0 mL) at rt for 3 h.
After evaporation of the solvent, the residue was purified by column chromatography with 1:1 EtOH-AcOEt to give an inseparable mixture of the 2-acetamido-3,6-O-dibenzyl-2,5-dideoxy-5-methoxyphosphoryl derivatives (24) as a colorless syrup: R f = 0.30-0.25 (B).
The compounds 24 dissolved in 1:1 EtOH-AcOEt (2.0 mL) was hydrogenated in the presence of 20% Pd(OH) 2 -C (3.0 mg) at rt under atmospheric pressure of hydrogen. After 24 h, the catalyst was filtered off and the filtrate was evaporated in vacuo. The residue was acetylated again with dry pyridine (1.0 mL) and acetic anhydride (0.20 mL). The mixture was evaporated in vacuo and the residue was sepalated by column chromatography with a gradient eluent of AcOEt to 1:9 EtOH-AcOEt into two fractions.
The faster-elutiong fraction [R f = 0.36-0.32 (B)] gave a colorless syrup (17.5 mg), which consisted of the 5-[(R)-methoxyphosphoryl]-α-D-glucopyranose (25a) (7.5% from 21a) and its 5-[(S)-P]-α-isomer (25c) (11.6%), the ratio being estimated by 1H NMR: 1 H and 31 P NMR, see Table 1 .
2-Acetamido-1,3,4,6-tetra-O-acetyl-2,5-dideoxy-5-methoxyphosphoryl-L-idopyranoses (29a-d).
The procederes similar to those for preparation of compounds 25 from 21a were employed. and 5-[(S)-P]-β-isomer (29c) (3.2%), the ratio being estimated by 1 
